RELX PLC PLC
לונג

RELX: The Essential Intelligence Layer for Law, Science, & Risk

21
ABOUT: RELX is a global provider of professional information, analytics and decision-making tools. Its products support scientific research, legal analysis, insurance underwriting, fraud detection, financial-crime compliance and other business-critical decisions. The company also operates major trade shows and professional events through its Exhibitions division.

The pitch is straightforward: RELX is a wide-moat information compounder transitioning from selling content to selling better decisions. Its proprietary data and workflow tools are embedded in legal, scientific, insurance and risk-management processes where accuracy and trust matter. Revenue grew 7% organically in 2025, operating profit grew 9%, EPS grew 10%, and cash conversion reached 99%. With AI improving the value of its products, margins still expanding and the supplied valuation sitting 41% below fair value, RELX offers an unusually attractive balance of quality, defensiveness and growth.

RELX offers a combination that is difficult to find:
Wide moat: proprietary data, trusted brands, workflow integration and switching costs.
Defensive growth: demand is connected to research, regulation, insurance, law and compliance rather than discretionary consumer spending.
Operating leverage: profit is growing faster than revenue.
AI monetization: RELX can charge for better professional outcomes, not merely access to generic information.
Valuation support: the supplied Morningstar estimate places the stock 41% below fair value.

STATS:

GreenBlue: 364 / 2,500
GreenRed: 439 / 2,712
Morningstar: 5 stars; 41% below fair value
Moat: Wide
Capital allocation: Exemplary
Fair-value uncertainty: Medium
GuruFocus: 79 / 100

Risks: AI lowers barriers to information retrieval or customers resist paying more for AI-enhanced products. The counterargument is that generic AI still requires RELX’s verified content, proprietary datasets, workflow integration, and professional-grade auditability.

Competitors: TRI, WKL, VRSK, SPGI, FDS, CLVT

כתב ויתור

המידע והפרסומים אינם מיועדים להיות, ואינם מהווים, ייעוץ או המלצה פיננסית, השקעתית, מסחרית או מכל סוג אחר המסופקת או מאושרת על ידי TradingView. קרא עוד ב־תנאי השימוש.